Comparison of Time to Treatment Between Intravenous and Endovascular Thrombolytic Treatments for Acute Ischemic Stroke

BACKGROUND: Intravenous (IV) recombinant tissue plasminogen activator (rt-PA) is used to treat acute ischemic stroke (AIS) within 4.5 hours of symptom onset. Endovascular treatment (ET) may provide higher rates of recanalization, but longer time to treatment may limit comparative clinical benefit an...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Asaithambi, Ganesh, Hassan, Ameer E., Chaudhry, Saqib A., Rodriguez, Gustavo J., Suri, M. Fareed K., Taylor, Robert A., Ezzeddine, Mustapha A., Qureshi, Adnan I.
Formato: Artigo
Idioma:Inglês
Publicado: Zeenat Qureshi Stroke Research Center 2011
Assuntos:
Original Contribution
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3317284/
https://ncbi.nlm.nih.gov/pubmed/22518266
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares